PREEMPTİVE PARA-CERVİCAL BLOCK FOR POSTOPERATİVE PAIN AFTER LAPAROSCOPIC HYSTERECTOMY
1 other identifier
interventional
166
1 country
2
Brief Summary
Total hysterectomy is one of the most common surgical procedure in gynecology. The laparoscopic route for the performance of hysterectomies are on the rise \[1\]. The laparoscopic hysterectomy (TLH) procedure has several advantages over open surgery such as better cosmetic outcomes, faster recovery earlier return to normal activities and work \[1-3\]. Nonetheless, postoperative pain (PP) remains an issue that scuppers these advantages \[1-3\]. The incidence of PP after TLH has been reported to vary from 35% to 63% \[4,5\]. The origin of PP after laparoscopy is multifactorial and complex such as perioperative predicaments, including pneumoperitoneum, stretching of the intraabdominal cavity, the blood left in the abdomen, and dissection of the pelvic region \[6-7\]. A randomized controlled trial has demonstrated that there may be more intense pain and greater analgesia requirements in the immediate postoperative period after laparoscopic surgery than after laparotomy \[8\]. Further inquiry to intercept the advancement and decrease the severity of PP is prominent to further improve TLH. Women undergoing TLH experience two different pain characteristics including incisional pain and visceral pain in the first hour after the operation \[6\]. These pains were most intense 30 min after TLH, gradually decreasing thereafter for postoperative 72 hr \[6\]. High levels of acute postoperative pain (APP) are pertain with an increment risk of chronic postsurgical pain so control of these acute pains in the urgent postoperative period is vital for faster amelioration. Many attempts have been tried to control APP after THL, such as transverse abdominal plane blocks, superior hypogastric plexus block, local anesthetic injection to the port side, and reduced port caliber \[9-12\]. Para-cervical bloc (PCB) is believed to block the Frankenhouser nerve plexus that supplies the visceral sensory fibers to the uterus, cervix, and top of the vagina. Only two randomized studies have assessed the effect of PCB in THL, but several limitations such as the small sample size preclude drawing conclusions on PP after TLH. Thus, the primary goal of this randomized clinical trial was to investigate if PCB at the onset of surgery, as a part of enhanced recovery protocol, could improve patient recovery after THL.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2022
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 17, 2022
CompletedFirst Posted
Study publicly available on registry
April 22, 2022
CompletedStudy Start
First participant enrolled
May 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 14, 2023
CompletedFebruary 22, 2023
February 1, 2023
8 months
April 17, 2022
February 21, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
visual analog scale (VAS) pain score
1 h postoperative visual analog scale (VAS) pain score
up to 1 hour after the procedure
Secondary Outcomes (2)
the quality of postoperative recovery
Up to 24 hours after the procedure
faces pain scale-revised score
up to 2,4,6,12 hours after the procedure
Study Arms (2)
Control
PLACEBO COMPARATORPrior to starting surgery after general anesthesia, the 10 mL of normal saline was performed by the primary surgeon. The syringe was injected with 5 mL on each side into the cervical stroma at 3 and 9 o'clock with a depth of 2 to 3 cm.
Study
EXPERIMENTALPrior to starting surgery after general anesthesia, thE 10 mL of 0.5% bupivacaine with epinephrine was performed by the primary surgeon. The syringe was injected with 5 mL on each side into the cervical stroma at 3 and 9 o'clock with a depth of 2 to 3 cm.
Interventions
Eligibility Criteria
You may qualify if:
- Patients undergoing total type A laparoscopic hysterectomy with or without additional surgery, such as salpingo-oophorectomy or salpingectomy
You may not qualify if:
- age \< 18 years
- refusal to provide consent
- inability to understand the study questionnaire
- severe psychiatric or mental disorder
- American Society of Anesthesiologists (ASA) physical status classification \> III
- history of regular narcotic use within 6 months of the surgery
- conversion to laparotomy
- operation time \> 90 min
- Additional procedures
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Mugla Sıtkı Kocman University Education and Research Hospital
Muğla, Mentese, 48000, Turkey (Türkiye)
Kemal Güngördük
Menteşe, Muğla, 48000, Turkey (Türkiye)
Related Publications (1)
Gungorduk K, Gulseren V, Tastan L, Ozdemir IA. Paracervical block before laparoscopic total hysterectomy: A randomized controlled trial. Taiwan J Obstet Gynecol. 2024 Mar;63(2):186-191. doi: 10.1016/j.tjog.2024.01.013.
PMID: 38485313DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Doctor, associate professor
Study Record Dates
First Submitted
April 17, 2022
First Posted
April 22, 2022
Study Start
May 1, 2022
Primary Completion
December 31, 2022
Study Completion
January 14, 2023
Last Updated
February 22, 2023
Record last verified: 2023-02